• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Results of continuous treatment (3 years) with disodium cromoglycate of patients with bronchial asthma and spastic bronchitis].

作者信息

Anastasatu C, Kercea V, Duţu S, Algeorge G

出版信息

Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1982 Jul-Sep;31(3):219-26.

PMID:6296977
Abstract

A group including 36 patients with bronchial asthma and 8 with spastic bronchitis have been treated with disodium cromoglycate for a period of 3 years starting with July 1-st, 1978. Eight of these patients also had allergic rhinitis, and in these ones administration of the treatment was also made by nasal application. Partial results have been published after 3 and 18 months of treatment. Of the original 44 patients 23 are still followed and the other 21 had been followed for at least 2 years, an interval which was considered as sufficient for eliminating seasonal variations of the asthmatic manifestations, independent from the treatment applied. The results at 3 years are different from those at 3 months and are relatively similar to those at 18 months. In 41.2% of the cases necessities for steroid therapy had been reduced, and in 30.3% of the cases a durable suppression of corticoid therapy was possible. With regard to bronchial dilators the doses have been diminished in 32.1% of the cases, and completely abandoned in 20.3% of the patients. A synthetic evaluation of clinical and laboratory results showed that these were positive in 68.3% of all cases. The treatment was well tolerated and no undesirable side effects were noted over the period of the treatment.

摘要

相似文献

1
[Results of continuous treatment (3 years) with disodium cromoglycate of patients with bronchial asthma and spastic bronchitis].
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1982 Jul-Sep;31(3):219-26.
2
[Disodium cromoglycate treatment of bronchial asthma and spastic bronchitis (preliminiary results)].
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1979 Jan-Mar;28(1):17-24.
3
[Role of intal in the reduction of corticosteroid doses in the treatment of bronchial asthma and chronic spastic bronchitis].
Pneumonol Pol. 1981 Aug-Sep;49(8-9):633-5.
4
Disodium cromoglycate, corticoids and bronchodilators in asthma therapy.
Acta Tuberc Pneumol Belg. 1974 May-Aug;65(3-4):413-7.
5
[Current position of disodium cromoglycate in the therapy of broncho-asthmatic syndromes].[色甘酸钠在支气管哮喘综合征治疗中的当前地位]
Arch Monaldi. 1972 Jan-Feb;27(1):35-43.
6
A double-blind trial of disodium cromoglycate (Intal) in the treatment of bronchial asthma.色甘酸钠(因他利)治疗支气管哮喘的双盲试验。
Can Med Assoc J. 1971 Oct 23;105(8):827-31.
7
[Results observed during treatment of various spastic broncho-pneumopathies with disodium cromoglycate].
Brux Med. 1972 Feb;52(2):135-41.
8
Treatment of bronchial asthma with disodium cromoglycate. Special indications.
Med Interne. 1981 Apr-Jun;19(2):185-9.
9
[2 years of experience with disodium cromoglycate in the therapy of bronchial asthma and chronic asthmatiform bronchitis].
Folia Allergol (Roma). 1972 Mar-Apr;19(2):112-6.
10
[Effectiveness of sodium cromoglycate in the reduction of bronchodilator doses in asthmatic patients].
Rev Alerg. 1992 Jul-Aug;39(4):74-80.